Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Clinical Evaluation of a New Form of Cancer Therapy Based on the Principles of Atavistic Metamorphosis (Atavistic Chemotherapy).

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02366884
Recruitment Status : Recruiting
First Posted : February 19, 2015
Last Update Posted : August 9, 2019
Sponsor:
Collaborator:
Instituto de Ciencia y Medicina Genomica, Torreon, Coah. Mexico www.institutodeciencia.com
Information provided by (Responsible Party):
Frank Arguello, MD, Dr. Frank Arguello Cancer Clinic

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : December 31, 2022
Estimated Study Completion Date : December 31, 2023